Panobinostat reduces hypoxia-induced cisplatin resistance of non-small cell lung carcinoma cells via HIF-1α destabilization
about
Sequential pathogenesis of metastatic VHL mutant clear cell renal cell carcinoma: putting it together with a translational perspectiveTurning on the Radio: Epigenetic Inhibitors as Potential Radiopriming AgentsEpigenetic Therapy for Solid Tumors: Highlighting the Impact of Tumor HypoxiaCisplatin treatment increases stemness through upregulation of hypoxia-inducible factors by interleukin-6 in non-small cell lung cancer.Metformin sensitizes the response of oral squamous cell carcinoma to cisplatin treatment through inhibition of NF-κB/HIF-1α signal axis.Scriptaid overcomes hypoxia-induced cisplatin resistance in both wild-type and mutant p53 lung cancer cells.The predictive value of ERCC1 and p53 for the effect of panobinostat and cisplatin combination treatment in NSCLC.HDACs and HDAC Inhibitors in Cancer Development and Therapy.α2,6-Sialylation mediates hepatocellular carcinoma growth in vitro and in vivo by targeting the Wnt/β-catenin pathway.Epigenome Aberrations: Emerging Driving Factors of the Clear Cell Renal Cell Carcinoma.Low hypoxia inducible factor-1α (HIF-1α) expression in testicular germ cell tumors - a major reason for enhanced chemosensitivity?Mxd1 mediates hypoxia-induced cisplatin resistance in osteosarcoma cells by repression of the PTEN tumor suppressor gene.Hypoxia-Induced Cisplatin Resistance in Non-Small Cell Lung Cancer Cells Is Mediated by HIF-1α and Mutant p53 and Can Be Overcome by Induction of Oxidative Stress.Knockdown of KLF5 suppresses hypoxia-induced resistance to cisplatin in NSCLC cells by regulating HIF-1α-dependent glycolysis through inactivation of the PI3K/Akt/mTOR pathway.The effect of combined treatment with sodium phenylbutyrate and cisplatin, erlotinib, or gefitinib on resistant NSCLC cells
P2860
Q26744089-D8EECBC2-977D-4BA3-AFE1-7167F55B2751Q26744212-97C826D2-1B26-4740-B257-DAD09385F98DQ26783014-2DA02D76-A91F-44C1-A0A3-5F895FF528E6Q37142438-A5800441-11BA-42CD-B676-B87983B3D52DQ37352852-FFB77265-EDB5-4C24-BBD4-6F6F2427BDABQ37687726-C1EFAB75-A06A-4DE4-9C0C-D075CEE03202Q38878715-BAE7492F-BC53-4982-A023-435C51CF02E6Q38947405-562E201A-AF4A-4D1F-9347-7AC0F0EAFF9EQ41098517-EA1D5490-5B2E-4176-81AD-28C8D599AF25Q41574276-EBE47F02-54AB-4388-BD1E-1A4B6B248DB9Q41662386-274D097D-863F-4160-9FF8-9AC2844E65EEQ47881043-19DDDE0A-5DB7-40B6-8166-FF4D4FEFA4DAQ53691994-67D3EEAE-661C-48C4-9F2D-B01685D26327Q55280857-47CB6923-7D2C-411B-A85A-62B63E6D217DQ57816535-4864854D-AB88-4FC4-A850-D7762CC7BC9A
P2860
Panobinostat reduces hypoxia-induced cisplatin resistance of non-small cell lung carcinoma cells via HIF-1α destabilization
description
2015 nî lūn-bûn
@nan
2015 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Panobinostat reduces hypoxia-i ...... lls via HIF-1α destabilization
@ast
Panobinostat reduces hypoxia-i ...... lls via HIF-1α destabilization
@en
type
label
Panobinostat reduces hypoxia-i ...... lls via HIF-1α destabilization
@ast
Panobinostat reduces hypoxia-i ...... lls via HIF-1α destabilization
@en
prefLabel
Panobinostat reduces hypoxia-i ...... lls via HIF-1α destabilization
@ast
Panobinostat reduces hypoxia-i ...... lls via HIF-1α destabilization
@en
P2093
P2860
P50
P356
P1433
P1476
Panobinostat reduces hypoxia-i ...... lls via HIF-1α destabilization
@en
P2093
Alexandra Bertsch
Andelko Hrzenjak
Carina Fischer
Christoph Wohlkoenig
P2860
P2888
P356
10.1186/1476-4598-14-4
P577
2015-01-21T00:00:00Z
P5875
P6179
1018302671